tenilsetam has been researched along with Diabetic Retinopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alt, A; Brownlee, M; Chavakis, T; Hammes, HP; Hoffmann, J; Lin, J; Lochnit, G; Preissner, KT; Schleicher, E; Schubert, U; Van der Woude, FJ | 1 |
1 other study(ies) available for tenilsetam and Diabetic Retinopathy
| Article | Year |
|---|---|
Tenilsetam prevents early diabetic retinopathy without correcting pericyte loss.
Topics: Animals; Cell Proliferation; Chelating Agents; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelium, Vascular; Humans; Leukocytes; Male; Pericytes; Piperazines; Rats; Rats, Wistar; Thiophenes; Vascular Endothelial Growth Factor A | 2006 |